2.28
9.62%
0.20
Brainstorm Cell Therapeutics Inc (BCLI) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Research and Development |
43.40%
0.961
|
1.698 | 3.33 | 2.794 | 2.924 |
Operating Income/Loss |
48.50%
-2.474
|
-4.804 | -6.035 | -5.449 | -5.151 |
Income/Loss From Continuing Operations Before Tax |
39.03%
-3.401
|
-5.578 | -1.226 | -5.329 | -5.059 |
Income/Loss From Continuing Operations After Tax |
39.03%
-3.401
|
-5.578 | -1.226 | -5.329 | -5.059 |
Net Income/Loss
|
39.03%
-3.401
|
-5.578 | -1.226 | -5.329 | -5.059 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,195%
64.74
|
2.8204 | 44.25 | 39.70 | 36.74 |
Diluted Average Shares |
2,195%
64.74
|
2.8204 | 44.25 | 39.70 | 36.74 |
Basic Earnings Per Share |
54.55%
-0.05
|
-0.11 | -0.03 | -0.13 | -0.14 |
Diluted Earnings Per Share |
54.55%
-0.05
|
-0.11 | -0.03 | -0.13 | -0.14 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):